A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Ezerosu Tab. 10/20 mg(Single-layer Tablet) Compared to Ezerosu Tab. 10/20 mg(Double-layer Tablet) in Healthy Adult Volunteers
Latest Information Update: 31 Jan 2024
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Shin Poong Pharmaceutical
Most Recent Events
- 31 Jan 2024 New trial record